These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 347801)

  • 21. [Immunological classification of acute lymphoblastic leukemias (author's transl)].
    Tubiana N; Derre M; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1993-7. PubMed ID: 6256912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the cells which originate from the thymus and bone marrow.
    Miller JF
    Ann Immunol (Paris); 1974 Jan; 125C(1-2):213-29. PubMed ID: 4142553
    [No Abstract]   [Full Text] [Related]  

  • 23. [Observation of surface markers of leukemic cells in three cases of chronic lymphatic leukemia (author's transl)].
    Park K; Kamitani T; Tatsumi Y; Im T; Tatsumi N; Kimura Y; Mahda H; Okuda K; Yamamoto S
    Rinsho Ketsueki; 1982 Jan; 23(1):91-9. PubMed ID: 6980302
    [No Abstract]   [Full Text] [Related]  

  • 24. [Membrane characteristics and functional analysis of human T and B lymphocytes].
    Schuurman RK
    Tijdschr Kindergeneeskd; 1981 Apr; 49(2):82-4. PubMed ID: 6455778
    [No Abstract]   [Full Text] [Related]  

  • 25. Monoclonal antibodies to a human T-cell antigen and Ia-like antigen in the characterization of lymphoid leukemia.
    Royston I; Omary MB; Trowbridge IS
    Transplant Proc; 1981 Mar; 13(1 Pt 2):761-6. PubMed ID: 7022944
    [No Abstract]   [Full Text] [Related]  

  • 26. Modulation of antigen processing and presentation by covalently linked complement C3b fragment.
    Jacquier-Sarlin MR; Gabert FM; Villiers MB; Colomb MG
    Immunology; 1995 Jan; 84(1):164-70. PubMed ID: 7890301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of complement in the immune response.
    Feldbush TL; Hobbs MV; Severson CD; Ballas ZK; Weiler JM
    Fed Proc; 1984 Jul; 43(10):2548-52. PubMed ID: 6610570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative pathway of complement activation by human lymphoblastoid B and T cell lines.
    Praz F; Lesavre P
    J Immunol; 1983 Sep; 131(3):1396-9. PubMed ID: 6604099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Population of double cell and null cell by the method of simultaneous observation of T and B surface markers].
    Hashimoto K; Park K; Kamitani T; Tatsumi Y; Im T; Tatsumi N; Okuda K
    Rinsho Byori; 1983 Feb; 31(2):189-93. PubMed ID: 6343676
    [No Abstract]   [Full Text] [Related]  

  • 30. Binding of soluble 125I-human C3b, the third component of complement, to specific receptors in human cultured B lymphoblastoids cells: characterization of a low affinity interaction.
    Frade R; Strominger J
    J Immunol; 1980 Sep; 125(3):1332-9. PubMed ID: 6967899
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunoglobulin-bearing and complement-receptor lymphocytes constitute the same population in human peripheral blood.
    Ehlenberger AG; McWilliams M; Phillips-Quagliata JM; Lamm ME; Nussenzweig V
    J Clin Invest; 1976 Jan; 57(1):53-6. PubMed ID: 1081992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Classification of acute leukemias by surface markers and correlation with the morphological diagnosis. Results of 111 cases].
    von Fliedner V; Carrel S; Morell A; Heumann D; Losa G; Hirt A; Jeannet M; Mach JP; Cruchaud A
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1524-6. PubMed ID: 6975992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immune adherence receptor: dissociation between the expression of erythrocyte and mononuclear cell C3b receptors.
    Rothman IK; Gelfand JA; Fauci AS; Frank MM
    J Immunol; 1975 Nov; 115(5):1312-5. PubMed ID: 1100727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface markers on leukemic blasts and their prognostic significance.
    Sen L; Estevez ME; Finiasz MR; Giuntoli J; Pavlovsky S; Sackmann-Muriel F; Divito J; Dibar E
    Medicina (B Aires); 1981; 41 Suppl():109-17. PubMed ID: 6980353
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunologic cell markers in lymphoproliferative diseases].
    Samoĭlova RS
    Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunologic deficiency diseases].
    Bläker F
    Internist (Berl); 1984 Jan; 25(1):21-7. PubMed ID: 6425237
    [No Abstract]   [Full Text] [Related]  

  • 38. Lymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targets.
    Ramos OF; Algarra I; Sármay G; Yefenof E; Gergely J; Klein E
    J Immunol; 1989 Jan; 142(1):217-23. PubMed ID: 2521233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B cell markers in Ph1-positive acute lymphoblastic leukemia.
    Alimena G; De Rossi G; Gastaldi R; Guglielmi C; Mandelli F
    Nouv Rev Fr Hematol (1978); 1980; 22(3):275-80. PubMed ID: 6970921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recognition of HLA and minor alloantigens on human target cells by allostimulated cytotoxic effectors in vitro.
    Pierson G; Elkins W
    Transplant Proc; 1981 Dec; 13(4):1901-5. PubMed ID: 6977223
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.